Table 1.

Comparison of evaluated parameters in the examined groups

Group	n	Demographics			Serum						CSF
		Age	Female	Male	NSE1	NSE2	NSE2/NSE1	S100B1	S100B2	S100B2/S100B1	NSE1	NSE2	NSE2/NSE1	S100B1	S100B2	S100B2/S100B1
I Meningoencephalitis	17	54.63 ± 13.18	5	12	17.5 ± 18.1	20.7 ± 15	2 ± 2	141.1 ± 80.2	51.4 ± 50.8	0.3 ± 0.3	12 ± 4.8	16.4 ± 7.9	1.6 ± 0.9	186.3 ± 47.5	188.6 ± 67.8	1 ± 0.5
Ia full recovery	11	53.9 ± 9.5	4	7	13.3 ± 5.2	34.3 ± 9.7	3.6 ± 0.9	148.5 ± 84.6	20.9 ± 30.2	0.1 ± 0.2	12.3 ± 5.6	19.3 ± 9.8	1.9 ± 1.3	191.1 ± 47.4	173.5 ± 60	1 ± 0.6
Ib sequelae	6	52.5 ± 16.3	1	5	20.5 ± 20.6	16.7 ± 15	1.52 ± 2	134.4 ± 72.1	61.6 ± 48.4	0.4 ± 0.2	10.2 ± 5.2	13.0 ± 6.9	1.4 ± 0.7	177.9 ± 55	167.9 ± 59.1	1 ± 0.5
p Ia versus Ib		ns	ns	ns	ns	0.04	0.04	ns	ns	ns	ns	ns	ns	ns	ns	ns
II Meningitis	26	50.32 ± 12.53	9	17	13.3 ± 10.8	17.7 ± 8.2	1.6 ± 1.7	127.3 ± 43.1	87.6 ± 53.5	0.5 ± 0.4	6.7 ± 6.7	13.6 ± 10	2.9 ± 3	185.6 ± 33.8	195.8 ± 44.8	1 ± 0.5
CG	13	52.31 ± 15.34	4	9	17.5 ± 6.3			80.8 ± 58.3			6.7 ± 2.2			183.9 ± 19.1
p‐Value I versus II					ns	ns	ns	ns	ns	ns	0.0002	ns	ns	ns	ns	ns
p‐Value I versus CG					ns	ns		ns	ns		0.04	ns		ns	ns
p‐Value II versus CG					ns	ns		ns	ns		ns	ns		ns	ns

CSF, cerebrospinal fluid; CG, control group.

p I versus II—comparison of analyzed parameters between Sample 1 and Sample 2.

p I versus CG—comparison of analyzed parameters between Sample 1 and control group.

p II versus CG—comparison of analyzed parameters between Sample 2 and control group.

S100B2/S100B1—ratio of S100B in Sample 2 to Sample 1.

NSE2/NSE1—ratio of NSE in Sample 2 to Sample 1.